Parallax Volatility Advisers
CCXI

Parallax Volatility Advisers’s ChemoCentryx, Inc. CCXI Stock Holding History

Parallax Volatility Advisers’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100
Closed -$4K – 3640
2021
Q4 		$4K Sell
100
-118,300
-100% -$4.15M ﹤0.01% 2901
2021
Q3 		$2.02M Sell
118,400
-335,900
-74% -$5.23M ﹤0.01% 1643
2021
Q2 		$6.08M Buy
+454,300
New +$11.2M 0.01% 1114
2016
Q2 		– Sell
-62,400
Closed -$155K – 3793
2016
Q1 		$155K Hold
62,400
– – ﹤0.01% 1843
2015
Q4 		$505K Buy
+62,400
New +$442K ﹤0.01% 1540

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Parallax Volatility Advisers's CCXI Position: Q1 2022 in Review

Parallax Volatility Advisers sold out of ChemoCentryx, Inc. (CCXI) in Q1 2022, closing a stake of 8,273 shares — an estimated $232K sold.

Parallax Volatility Advisers first reported a position in CCXI in Q4 2015 and held it in 6 quarters. The position peaked at $3.27M in Q2 2021. 176 funds tracked by Wall St. Rank hold CCXI as of Q1 2022.

  • Parallax Volatility Advisers reported no remaining ChemoCentryx, Inc. position as of Q1 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 8,273 ChemoCentryx, Inc. shares in Q1 2022, an estimated $232K.
  • Parallax Volatility Advisers first reported a position in ChemoCentryx, Inc. in Q4 2015 and held it in 6 quarters.
  • Parallax Volatility Advisers's ChemoCentryx, Inc. position peaked at $3.27M in Q2 2021.
  • 176 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2022.

Based on Parallax Volatility Advisers's 13F filing for Q1 2022, filed 16 May 2022.